共 49 条
- [1] Leaf C.(2004)Why we’re losing the war on cancer (and how to win it) Fortune. 149 76-76
- [2] Garattini S(2002)Efficacy, safety, and cost of new anticancer drugs BMJ. 325 269-271
- [3] Bertele V(2007)Oncolytic viruses in cancer therapy Cancer Lett. 254 178-216
- [4] Vaha-Koskela MJ(2010)Neoadjuvant therapy of colorectal liver metastases: lessons learned from clinical trials J Surg Oncol. 102 932-936
- [5] Heikkila JE(2010)Optimum chemotherapy regimens for neoadjuvant therapy of hepatic colorectal metastases J Surg Oncol. 102 946-954
- [6] Hinkkanen AE(2010)Evolution of neoadjuvant therapy for extended hepatic metastases—have we reached our (non-resectable) limit? J Surg Oncol. 102 922-931
- [7] Brouquet A(1997)Update on hepatic intra-arterial chemotherapy Oncology (Williston Park). 11 947-957
- [8] Nordlinger B(2006)Advances in oncolytic viral therapy Curr Opin Investig Drugs. 7 549-559
- [9] Davies JM(2006)China approves world’s first oncolytic virus therapy for cancer treatment J Natl Cancer Inst. 98 298-300
- [10] Goldberg RM(2007)Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus Cancer Res. 67 10038-10046